Drug recalls
Every medicine recall reported to the FDA since 2012, newest first. Last checked for new ones 19 hours ago.
18,166 recalls
- Class III Primidone Tablets, USP, 250 mg, 100-count bottle, RX only, Manufactured by: Lannett Company, Inc., Marketed by: GSMS, Incorporated, Camarillo, CA 93012. Cross contamination with other products: API contaminated with trace amounts of Acemetacin API. Golden State Medical Supply Inc. · May 27, 2026 · Ongoing
- Class III Primidone Tablets, USP, 50 mg, 50-count bottle, RX only, Manufactured by: Lannett Company, Inc., Marketed by: GSMS, Incorporated, Camarillo, CA 93012. Cross contamination with other products: API contaminated with trace amounts of Acemetacin API. Golden State Medical Supply Inc. · May 27, 2026 · Ongoing
- Class III Primidone Tablets USP, 250mg, 100-count bottle, Rx only, Distributed by: Lannett Company, Inc., Philadelphia, PA 19136, NDC 0527-1231-01. Cross contamination with other products: API contaminated with trace amounts of Acemetacin API. Lannett Company Inc. · May 27, 2026 · Ongoing
- Class II Ascend Laboratories, LLC, Metoprolol Succinate Extended-Release Tablets, USP, 25 mg* Rx Only, Manufactured by: Alkem Laboratories Ltd., India, Distributed by: A… Failed Dissolution Specifications Ascend Laboratories, LLC · May 20, 2026 · Ongoing
- Class II Buprenorphine Hydrochloride, Injection, 0.3mg/mL, 5x1 mL Single Dose Vials, Rx only, Manufactured for: Endo USA, Malvern, PA 19855, NDC 42023-179-05. Crystallization; identified as Buprenorphine free base ENDO USA, Inc. · May 20, 2026 · Ongoing
- Class II Oasis Tears PF, Preservative-Free Lubricant Eye Drops, 10mL/0.34 Fl OZ Bottle, Sterile, Manufactured for: OASIS Medical, Inc., 514 S. Lack of Assurance of Sterility: The recall is being initiated out of an abundance of caution following FDA observations noted during a recent inspection of Exce… Oasis Medical, Inc. · May 20, 2026 · Ongoing
- Class I Lactated Ringer's Injection USP, 1000 mL container, Rx only, B. Braun Medical, Inc., Bethlehem, PA 18018-3524 USA, NDC 0264-7750-07. Presence of Particulate Matter. B Braun Medical Inc · May 13, 2026 · Ongoing
- Class II TPN bag (patient specific), Rx# 11-4909703-0-1, Compound Volume 1660 mL per bag, Rx only, Single Dose Injection, Refrigerated Injection, Central Admixture Pharm… Incorrect Product Formulation: product did not contain insulin as listed in the label. Central Admixture Pharmacy Services, Inc (CAPS) Los Angeles · May 13, 2026 · Ongoing
- Class II NAPROXEN ORAL SUSPENSION, USP, 125 mg/5mL, Rx only, 16fl oz (473 mL) bottles, Distributed by: Acella Pharmaceuticals, LLC, Alpharetta, GA 30005, Made in Canada… Chemical contamination; presence of lead and lithium above specification Acella Pharmaceuticals, LLC · May 13, 2026 · Ongoing
- Class II Duloxetine Delayed-Release Capsules USP, 60mg, Rx Only, 90-count bottle, Mfr. by Towa Pharmaceutical Eurpoe S.L., Martorelles, (Barcelona), Spain, Dist. by. CGMP Deviations; presence of N-nitroso-duloxetine impurity above the FDA recommended limit Breckenridge Pharmaceutical, Inc. · May 13, 2026 · Ongoing
- Class II Enalapril Maleate Tablets, USP, 20 mg, 1,000-count bottle, Rx only, Manufactured by: Unique Pharmaceutical Laboratories (A Div. of J.B. Failed Impurities/Degradation Specifications:Out of specification result occurred in Organic Impurities Test JB Chemicals and Pharmaceuticals Ltd · May 13, 2026 · Ongoing
- Class II Octreotide Acetate for Injectable Suspension, for gluteal intramuscular use, 30 mg, In Single-Dose kits containing: 8-mL vial of 30 mg strength, a pre-filled sy… Lack of Assurance of Sterility: Quality system deficiencies identified during a routine U.S Food and Drug Administration (FDA) inspection at the contract manufa… Teva Pharmaceuticals USA, Inc · May 13, 2026 · Ongoing
- Class II BD PurPrep, Povidone-iodine 8.3% w/w (0.83% available iodine) with isopropyl alcohol 72.5% w/w Sterile Solution, 0.36 fl. oz. Lack of assurance of Sterility: potential product contamination CareFusion 213, LLC · May 13, 2026 · Ongoing
- Class II BD PurPrep, Povidone-iodine 8.3% w/w (0.83% available iodine) with isopropyl alcohol 72.5% w/w Sterile Solution, 25x26mL Applicators per carton. Lack of assurance of Sterility: potential product contamination CareFusion 213, LLC · May 13, 2026 · Ongoing
- Class II Duloxetine Delayed-Release Capsules, 20 mg, Rx Only, 60 capsules, Marketed by: Ajanta Pharma USA Inc., Bridgewater, NJ 08807, Made in India, NDC 27241-097-06. CGMP Deviations: Presence of N-nitroso-Duloxetine impurity above FDA recommended limit of 0.83 ppm, identified at the 12-month and 18-month long-term stability… Ajanta Pharma Ltd. · May 13, 2026 · Ongoing
- Class II Duloxetine Delayed-Release Capsules, 60 mg, Rx Only, 30 capsules, Marketed by: Ajanta Pharma USA Inc., Bridgewater, NJ 08807, Made in India, NDC 27241-099-03 CGMP Deviations: Presence of N-nitroso-Duloxetine impurity above FDA recommended limit of 0.83 ppm, identified at the 12-month and 18-month long-term stability… Ajanta Pharma Ltd. · May 13, 2026 · Ongoing
- Class II Duloxetine Delayed-Release Capsules, 30 mg, Rx Only, a) 90 Capsules, NDC 27241-098-09, b) 30 capsules, NDC 27241-098-03, c) 1000 Capsules, NDC 27241-098-10, Mar… CGMP Deviations: Presence of N-nitroso-Duloxetine impurity above FDA recommended limit of 0.83 ppm, identified at the 12-month and 18-month long-term stability… Ajanta Pharma Ltd. · May 13, 2026 · Ongoing
- Class II DELFLEX, Dextrose Peritoneal Dialysis Solution with attached stay-safe Exchange Set for Intraperitoneal Dialysis Only, 2.5% DEX. Lack of Assurance of Sterility: Potential leaks from perforations in bags. Fresenius Medical Care Holdings, Inc. · May 13, 2026 · Ongoing
- Class II DELFLEX, Dextrose Peritoneal Dialysis Solution with attached stay-safe Exchange Set for Intraperitoneal Dialysis Only, 1.5% DEX. Lack of Assurance of Sterility: Potential leaks from perforations in bags. Fresenius Medical Care Holdings, Inc. · May 13, 2026 · Ongoing
- Class III busPIRone Hydrochloride Tablets, USP, 5 mg, 500-count bottle, Rx Only, Manufactured by Unichem Laboratories LTD., Ind, Area, Meerut Road, Ghazibad - 201 003, In… Subpotent drug Unichem Pharmaceuticals USA Inc. · May 13, 2026 · Ongoing